Recent Quotes
My Watchlist
Indicators
Local Stocks
Local Stocks
Energy Stocks
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Biogen, Inc. (NQ: BIIB )

270.38 USD -3.46 (-1.26%)
Streaming Delayed Price Updated: 12:10 PM EST, Jan 20, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Biogen, Inc.

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
How Does Biogen's Debt Look Like?
Over the past three months, shares of Biogen Inc. (NASDAQ: BIIB) fell by 5.50%. Before having a look at the importance of debt, ... 
Tags News Debt Insights BIIB
From Benzinga
5 Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that ... 
Tags BIIB Biotechnology Market News
From Benzinga
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Although there were promising updates from some coronavirus vaccine makers, negative headlines plagued Novavax, Inc. and Moderna Inc., sending their stocks lower by 4.7% and 23%, respectively, for the... 
Tags Healthcare Pharma/Biotech Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Spotlight On GW Pharma, Ultragenyx FDA Decisions, Pfizer Earnings
Biotech stocks moved lower in the week ended July 26, as the broader market weakness and sector-specific developments pressured ... 
Tags ELAN NVAX ALNY
From Benzinga
Here's Why Biogen Just Blew Its Q2 Earnings Out of the Water
It wasn't because of revenue growth. 
Tags BIIB SGMO Market News
From Motley Fool
Biogen Inc (BIIB) Q2 2020 Earnings Call Transcript
BIIB earnings call for the period ending June 30, 2020. 
Tags BIIB Market News
From Motley Fool
Biogen Beats Second-Quarter Expectations
The biotech, which specializes in treating neurological diseases, may have topped estimates, but its stock barely moved. 
Tags BIIB RHHB/Y Market News
From Motley Fool
Coronavirus update: U.S. case tally climbs above 3.9 million as Trump finally urges Americans to wear face masks
The number of U.S. cases of the coronavirus illness COVID-19 climbed above 3.9 million on Wednesday, a day after President Donald Trump finally encouraged Americans to wear face masks in public,... 
Tags Health/Care General BNTX
From MarketWatch
Biogen (BIIB) Beats on Q2 Earnings, Raises EPS View, Stock Up
Biogen reported second-quarter 2020 earnings per share of $10.26. 
Tags Stocks / Equities
From Blogs - TalkMarkets
Morning Market Stats in 5 Minutes
Movers Indices • S&P 500 ETF (NYSE:SPY) fell 0.09% to $324.60. • Nasdaq ETF (NASDAQ:QQQ) increased 0.07% to ... 
Tags XLK QQQ XRT
From Benzinga
Biogen Earnings Easily Beat Views; Biotech Giant Rises
Biogen earnings handily beat second-quarter views, while revenue narrowly beat. The biotech giant raised full-year EPS targets. Biogen stock rose early Tuesday. 
From Investor's Business Daily
The Daily Biotech Pulse: Aurinia's Kidney Inflammation Drug Filing Accepted For Review, Intuitive Surgical's Q2 Beat
Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 21) ABIOMED, Inc. (NASDAQ: ABMD) Assembly Biosciences Inc ... 
Tags Pre/Market Outlook BLFS BMRN
From Benzinga
Dow slips as China-U.S. tensions seen ratcheting up, while investors watch for earnings from Tesla, Microsoft
U.S. stocks were indicated modestly lower on Wednesday as investors watch signs of Sino-American testiness and ready for corporate results from major corporations, including Tesla and Microsoft. 
Tags UK:UKX CLQ20 SNAP
From MarketWatch
A Peek Into The Markets: US Stock Futures Drop; Microsoft, Tesla Earnings In Focus
Pre-open movers U.S. stock futures traded lower in early pre-market trade, after closing mostly higher in the previous session. ... 
Tags News Earnings Markets
From Benzinga
7 Stocks To Watch For July 22, 2020
Some of the stocks that may grab investor focus today are: Wall Street expects Microsoft Corporation (NASDAQ: MSFT) to report ... 
Tags MSFT Stocks to Watch TSLA
From Benzinga
Earnings Scheduled For July 22, 2020
Companies Reporting Before The Bell • ABB Inc. (NYSE:ABB) is estimated to report quarterly earnings at $0.10 per share on ... 
Tags ARR DFS GGG
From Benzinga
Noteworthy Tuesday Option Activity: DIS, BAC, BIIB
Looking at options trading activity among components of the S&P 500 index, there is noteworthy activity today in Walt Disney Co. (DIS), where a total volume of 76,325 contracts has been traded thus far... 
Tags Stocks
From Market News Video
Tesla To Deliver Stock Reality Check; Microsoft, Chipotle Due: Investing Action Plan
The Tesla earnings report will provide hard numbers against a rally that has seen the stock more than triple in just the last three months. 
From Investor's Business Daily
Credit Suisse Upgrades Gilead On Remdesivir Commercial Opportunity
The biotech sector is a surefire winner due to atwo-pronged benefit from the coronavirus pandemic,according to an analyst at ... 
Tags Evan Seigerman NBIX Trading Ideas
From Benzinga
Jazz Awaits FDA Nod For Sleep Disorder Drug, Earnings Trickle In, ACell IPO
Biotech stocks advanced in the week ended July 17 thanks to positive broader market sentiment, encouraging news flow on the COVID-19 front, and fairly positive results reported by pharma giant Johnson... 
Tags Pharma/Biotech Healthcare Stocks / Equities
From Blogs - TalkMarkets
The Week Ahead In Biotech: Jazz Awaits FDA Nod For Sleep Disorder Drug, Earnings Trickle In, ACell IPO
Biotech stocks advanced in the week ended July 17thanks to positive broader market sentiment, encouraging news flow on the ... 
Tags Top Stories JNJ EW
From Benzinga
AC Immune Stock Catapults To Two-Year High On Alzheimer's News
AC Immune surged in massive volume Thursday after the small biotech company began dosing patients with an Alzheimer's treatment. The drug will be tested over 48 weeks in early-stage patients. 
From Investor's Business Daily
Commit To Buy Biogen At $235, Earn 14.1% Annualized Using Options
Investors considering a purchase of Biogen Inc (BIIB) shares, but cautious about paying the going market price of $280.46/share, might benefit from considering selling puts among the alternative... 
Tags Stocks
From Market News Video
4 Ways Biogen's Tecfidera Generic Battle Could Play Out For The Stock
Biogen Inc (NASDAQ: BIIB) is caught in more than one legal wrangle with generic companies over patents related to its key multiple ... 
Tags BIIB Analyst Ratings Analyst Color
From Benzinga
Tiny Biotech Skyrockets To A Record High On Promising Alzheimer's News
Inmune Bio stock skyrocketed to a record high Tuesday after the biotech company unveiled promising results for its Alzheimer's treatment. The drug targets inflammation in the brain. 
From Investor's Business Daily
The Daily Biotech Pulse: Blueprint, Roche Ink $1.7B Cancer Drug Collaboration, INmune's Positive Alzheimer's Readout, Edwards, Abbott Settle Patent Lawsuits
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags BCLI SONN VNRX
From Benzinga
The Daily Biotech Pulse: FDA Nod For Osmotica, OptiNose Strikes Co-promotion Deal, Orphan Drug Designation For AnaptysBio
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ARGX MCRB Offerings
From Benzinga
Why Biogen Stock Jumped Today
The biotech submitted a highly anticipated regulatory filing. 
Tags Market News BIIB
From Motley Fool
Biogen Shares Spike on Alzheimer's Update
The market is cheering progress for the company's Alzheimer's disease candidate. 
Tags Market News BIIB
From Motley Fool
Biogen Lifts Nasdaq to Near-Record; JD.com Leads China Internet Stocks Higher
The Nasdaq once again led the way for the broader stock market. 
Tags TCEH/Y SINA Market News
From Motley Fool
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.